Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings

Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, surpassing the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange [3] Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program, aiming to reaccelerate growth amid global market uncertainties [2] - Organic sales growth is projected at 1%–2%, with approximately 70 basis points impact from exiting private-label pet sales [3] Analyst Ratings and Price Targets - Wells Fargo maintained an Underweight rating, lowering the price target from $80 to $77 [6] - Evercore ISI Group maintained an Outperform rating, reducing the price target from $100 to $94 [6] - JP Morgan and Morgan Stanley both maintained Overweight ratings, with price targets adjusted from $88 to $87 and from $96 to $87, respectively [6] - Citigroup maintained a Buy rating, significantly lowering the price target from $105 to $95 [6]